Evidence map›Paper›PMID 34310633›Full record

ArticlePloS one2021

Seroprevalence and associated factors of HIV and Hepatitis C in Brazilian high-security prisons: A state-wide epidemiological study.

Lirane Elize Defante Ferreto, Stephanny Guedes, Fernando Braz Pauli, Samyra Soligo Rovani, Franciele Aní Caovilla Follador, Ana Paula Vieira, Renata Himovski Torres, Harnoldo Colares Coelho, Guilherme Welter Wendt

Erratum issuedAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Lirane Elize Defante FerretoWestern Paraná State University, Health Sciences Center, Faculty of Medicine, Public Health Lab, Francisco Beltrão, Brazil.ORCID 0000-0002-0757-3659
Stephanny GuedesWestern Paraná State University, Faculty of Medicine, Cascavel, Brazil.ORCID 0000-0002-0574-2535
Fernando Braz PauliWestern Paraná State University, Health Sciences Center, Postgraduate Program in Applied Health Sciences, Francisco Beltrão, Brazil.ORCID 0000-0003-3473-2739
Samyra Soligo RovaniWestern Paraná State University, Health Sciences Center, Postgraduate Program in Applied Health Sciences, Francisco Beltrão, Brazil.
Franciele Aní Caovilla FolladorWestern Paraná State University, Health Sciences Center, Postgraduate Program in Applied Health Sciences, Francisco Beltrão, Brazil.ORCID 0000-0002-9210-1540
Ana Paula VieiraWestern Paraná State University, Health Sciences Center, Postgraduate Program in Applied Health Sciences, Francisco Beltrão, Brazil.
Renata Himovski TorresDivision of Public Security and Penitentiary Administration, Penitentiary Department, Curitiba, Brazil.
Harnoldo Colares CoelhoSão Paulo State University, Department of Pharmacy, Ribeirão Preto, Brazil.ORCID 0000-0001-9983-5726
Guilherme Welter WendtWestern Paraná State University, Health Sciences Center, Faculty of Medicine, Public Health Lab, Francisco Beltrão, Brazil.ORCID 0000-0002-9014-6120

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The prevalence of hepatitis C virus (HCV) and the acquired immunodeficiency virus (HIV) is much higher in prisons than in community settings. Some explanatory factors for this burden include putative aspects of the prison environment, such as unprotected sexual relations and sexual violence, use of injectable drugs and syringe sharing. Nonetheless, efforts in better understanding the dynamics of both HCV and HIV are scarce in developing countries such as Brazil, which poses a risk not only to the inmates but to the community as well. In this investigation, we sought to determine the seroprevalence and sociodemographic and behavioral risk factors associated with HIV and anti-HCV antibodies among men detained at high-security institutions. This is an epidemiological, proportionally stratified observational study including 1,132 inmates aged 18 to 79 years-old (Mage = 32.58±10.18) from eleven high-security prisons located in the State of Paraná, Brazil. We found that HIV and anti-HCV prevalence were 1.6% (95% CI: 1.0-2.5) and 2.7% (95% CI: 1.0-2.5), respectively. Risk factors associated with HIV included not receiving intimate visits (OR = 8.80, 95% CI: 1.15-66.88), already having another sexually transmitted infection (OR = 3.89, 95% CI: 1.47-10.29), and reporting attendance in HIV preventive campaigns (OR = 4.24, 95% CI: 1.58-11.36). Moreover, anti-HCV seroprevalence was associated with higher age (OR = 4.03, 95% CI: 1.61-10.07), criminal recidivism (OR = 2.58, 95% CI 1.02-6.52), and the use of injectable drugs (OR = 7.32, 95% CI 3.36-15.92). Although prisons might increase the risk for acquiring and transmitting HIV and HCV, the adoption of permanent epidemiological surveillance programs could help reducing the circulation of viruses, involving strategies focusing on screening, treating, and preventing infections to assure proper prisoner health. Moreover, these policies need to take place inside and outside the prison environment to offer continued assistance to former prisoners once they leave the institution.

Indexed as

AdolescentAdultAgedBrazilHepatitis CHepatitis C AntibodiesHIV AntibodiesHIV InfectionsHumansMaleMiddle AgedPrevalencePrisonersRisk FactorsSexually Transmitted DiseasesSubstance-Related DisordersHepatitis C AntibodiesHIV Antibodies

Identifiers

PMID34310633
PMCPMC8312944

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.